SALT LAKE CITY — The use of sulfur hexafluoride was a predictor for greater endothelial cell loss after Descemet membrane endothelial keratoplasty, but the benefits may outweigh the risks, according to researchers.
Jules Leterrier, who presented the study at the Association for Research in Vision and Ophthalmology meeting, told Healio his center used only air for graft tamponade for years and switched to sulfur hexafluoride (SF6) in 2015.
“We have both data available,” he said. “We compared that and found that SF6 could, in fact, affect [endothelial cell loss].”